Thermo Fisher (NYSE: TMO) CFO details stock and option stake
Rhea-AI Filing Summary
Thermo Fisher Scientific Inc. senior vice president and CFO James Meyer filed an initial ownership statement reporting his equity stake in the company. The filing shows direct ownership of 5,841.4637 shares of common stock and an additional 50.03 shares held indirectly through a 401(k) plan.
He also reports multiple stock option awards on Thermo Fisher common stock with exercise prices ranging from 430.7300 to 635.1000 per share and expiration dates between 2028 and 2035. Individual grants include, for example, 6,851 underlying shares at an exercise price of 513.6800 and 3,598 underlying shares at an exercise price of 430.7300, reflecting substantial unexercised option-based exposure.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (10)
- F1. The options vested in four equal installments on February 23, 2022, 2023, 2024, and 2025.
- F2. The options vested in four equal installments on November 1, 2022, 2023, 2024, and 2025.
- F3. The options vested in four equal installments on February 28, 2023, 2024, 2025, and 2026.
- F4. The options vest in four equal annual installments. Three-quarters of the options vested on February 22, 2024, 2025, and 2026, and the remaining one-quarter will vest on February 22, 2027.
- F5. The options vest in four equal annual installments. Three-quarters of the options vested on February 28, 2024, 2025, and 2026, and the remaining one-quarter will vest on February 28, 2027.
- F6. The options vest in four equal annual installments. Two-quarters of the options vested on February 28, 2025 and 2026, and the remaining two-quarters will vest on February 28, 2027 and 2028.
- F7. The options vest in four equal annual installments. Two-quarters of the options vested on February 28, 2025 and 2026, and the remaining two-quarters will vest on February 28, 2027 and 2028.
- F8. The options vest in four equal annual installments. One-quarter of the options vested on February 28, 2026, and the remaining three-quarters will vest on February 28, 2027, 2028 and 2029.
- F9. The options vest in four equal annual installments on July 10, 2026, 2027, 2028 and 2029.
- F10. The options vest in four equal annual installments on February 28, 2027, 2028, 2029 and 2030.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Thermo Fisher (TMO) CFO James Meyer report in this Form 3?
James Meyer reports his initial ownership of Thermo Fisher equity, including common shares and stock options. The statement lists 5,841.4637 common shares held directly, 50.03 shares via a 401(k), and several option grants over Thermo Fisher common stock with varying exercise prices and expirations.
What stock option positions does the Thermo Fisher (TMO) CFO disclose?
James Meyer discloses multiple stock option awards on Thermo Fisher common stock. These include grants such as 6,851 underlying shares at a 513.6800 exercise price and 3,598 underlying shares at 430.7300, with option expiration dates stretching from 2028 through 2035.
Are there any buy or sell transactions in this Thermo Fisher (TMO) Form 3?
No buy or sell transactions are reported in this Form 3. All entries are categorized as holdings, showing existing common stock and option positions, rather than new purchases, sales, exercises, or dispositions during the period covered by the ownership report.
How do the Thermo Fisher (TMO) CFO’s options vest according to the footnotes?
The footnotes state that various option grants vest in four equal annual installments. Some options are already fully vested, while others vest over future dates, including schedules extending through February 2030, reflecting a multi-year compensation and retention structure.
What are the exercise price range and expirations of the Thermo Fisher (TMO) CFO’s options?
The reported stock options carry exercise prices from 430.7300 to 635.1000 per share. Option expiration dates run from February 23, 2028, through July 10, 2035, indicating long-dated incentives aligned with Thermo Fisher’s longer-term performance horizon.